These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [A case of granulomatous rosacea coinciding with the use of etanercept: no relapse with infliximab]. Winter UM; Treudler R; Paasch U; Sticherling M; Simon JC Hautarzt; 2008 Sep; 59(9):724-7. PubMed ID: 18465064 [TBL] [Abstract][Full Text] [Related]
30. Biological agents in the treatment of psoriasis. Tzu J; Krulig E; Cardenas V; Kerdel FA G Ital Dermatol Venereol; 2008 Oct; 143(5):315-27. PubMed ID: 18833073 [TBL] [Abstract][Full Text] [Related]
31. Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study. Esposito M; Gisondi P; Cassano N; Ferrucci G; Del Giglio M; Loconsole F; Giunta A; Vena GA; Chimenti S; Girolomoni G Br J Dermatol; 2013 Sep; 169(3):666-72. PubMed ID: 23647206 [TBL] [Abstract][Full Text] [Related]
32. Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review. Brezinski EA; Follansbee MR; Armstrong EJ; Armstrong AW Curr Pharm Des; 2014; 20(4):513-28. PubMed ID: 23565632 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of tumor necrosis factor inhibitors in acute generalized pustular psoriasis. Viguier M; Aubin F; Delaporte E; Pagès C; Paul C; Beylot-Barry M; Goujon C; Rybojad M; Bachelez H; Arch Dermatol; 2012 Dec; 148(12):1423-5. PubMed ID: 23247492 [No Abstract] [Full Text] [Related]
34. Experience with biologics for psoriasis in daily practice: switching is worth a try. Lecluse LL; de Groot M; Bos JD; Spuls PI Br J Dermatol; 2009 Oct; 161(4):948-51. PubMed ID: 19663876 [No Abstract] [Full Text] [Related]
35. An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis. Weinberg JM Clin Ther; 2003 Oct; 25(10):2487-505. PubMed ID: 14667953 [TBL] [Abstract][Full Text] [Related]
36. Adalimumab vs. etanercept in psoriasis. Downs AM Clin Exp Dermatol; 2007 Sep; 32(5):593. PubMed ID: 17692064 [No Abstract] [Full Text] [Related]
37. Efficacy of etanercept in psoriatic patients previously treated with infliximab. Pitarch G; Sánchez-Carazo JL; Mahiques L; Oliver V Dermatology; 2008; 216(4):312-6. PubMed ID: 18230978 [TBL] [Abstract][Full Text] [Related]
38. Successful treatment of hidradenitis suppurativa with infliximab in a patient who failed to respond to etanercept. Poulin Y J Cutan Med Surg; 2009; 13(4):221-5. PubMed ID: 19706231 [TBL] [Abstract][Full Text] [Related]
39. [The role of biological drugs in the treatment of psoriasis, results from 9 randomized placebo-controlled trials]. Kemény L; Brodszky V; Kárpáti K; Gulácsi L Orv Hetil; 2006 May; 147(21):981-90. PubMed ID: 16812973 [TBL] [Abstract][Full Text] [Related]
40. Switching to adalimumab in patients with moderate to severe psoriasis who have failed on etanercept: a retrospective case cohort study. Woolf RT; Smith CH; Robertson K; Barker JN Br J Dermatol; 2010 Oct; 163(4):889-92. PubMed ID: 20854408 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]